Asia-Pacific journal of clinical oncology · 2026
The Present and Future of THERANOSTICS.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lam Winnie Wing-Chuen, Thang Sue Ping, Loke Kelvin Siu-Hoong, Ngam Pei Ing, Tan Andrew Eik-Hock, Cheng Lenith Tai-Jit, Yu Sidney, Ler Anna, Khor Damian Li-Kin, Somanesan Soma, Ng David Chee Eng
Аннотация
There is a growing worldwide interest in the detection and targeted treatment of cancer with radiotheranostics as part of precision medicine. This article reviews some of the developments in theranostics, namely, approved radiopharmaceuticals, agents in late-stage clinical trials, emerging radionuclides and targets, as well as operational and regulatory challenges. Other areas of development include use of novel ligands, new indications, and combinations with other systemic therapies. We aim to provide an overview of radiopharmaceutical therapies in use and in clinical development and consider some of the challenges in East and Southeast Asia, including an innovative yet highly regulated environment in Singapore.